Endotoxin Control and Clearance in Biomanufacturing
WEBINAR
Endotoxin, a lipopolysaccharide (LPS), is a type of pyrogen and is a component of the exterior cell wall of gram-negative bacteria. To ensure the safety of a patient, endotoxin content in the drug should always be controlled. In biological processing, it may emanate from facility, utility, raw materials, process, and personnel.
In this webinar, you will learn:
- Sources of endotoxin contamination
- Contamination control strategy
- Endotoxin removal strategies
Speakers
Somasundaram G (Som)
Merck
Senior Consultant
Som is a consultant with customers for regulatory compliance, closed processing, and other areas in biopharmaceutical applications. He is also a member of PDA and ISPE industry associations. Som has worked in different functions within Merck for the last 19 years, including heading technology management, tech service, BioReliance® filter validation lab, commercial role, and business development areas. He also worked for a year in QA/QC as well as obtained one year of academic experience in microbiology.
Subhasis Banerjee, Ph.D.
Merck
Principal Process Consultant, APAC
Subhasis Banerjee is the Principal Process Consultant in the Technical & Scientific Solutions group of Process Solutions at our company based out of Bangalore, India. Subhasis supports technical consultation on Process Development , Scaleup and troubleshooting for downstream processing for the APAC region, working for the last 18 years in our company. He is a Ph.D. in Biochemistry with a post-doctoral experience from The Ohio State University, Columbus, Ohio, USA. Dr. Banerjee has several publications in international peer reviewed journals and presentations in several national and International Conferences.
Pharma and biopharma manufacturing
- Downstream Processing
Duration:1h 9min
Language:English
Session 1:presented February 22, 2022
To continue reading please sign in or create an account.
Don't Have An Account?